This article has Open Peer Review reports available.
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
© The Author(s). 2018
Received: 25 January 2017
Accepted: 21 December 2017
Published: 2 January 2018
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|25 Jan 2017||Submitted||Original manuscript|
|6 Mar 2017||Reviewed||Reviewer Report - Anthony C Faber|
|18 Mar 2017||Reviewed||Reviewer Report - Muhammad Shahdaat Bin Sayeed|
|15 May 2017||Author responded||Author comments - Toshihiko Kaneda|
|Resubmission - Version 2|
|15 May 2017||Submitted||Manuscript version 2|
|23 Aug 2017||Reviewed||Reviewer Report - Ikuo Sekine|
|4 Oct 2017||Reviewed||Reviewer Report - Anthony C Faber|
|3 Dec 2017||Author responded||Author comments - Toshihiko Kaneda|
|Resubmission - Version 3|
|3 Dec 2017||Submitted||Manuscript version 3|
|13 Dec 2017||Reviewed||Reviewer Report - Ikuo Sekine|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|21 Dec 2017||Editorially accepted|
|2 Jan 2018||Article published||10.1186/s12885-017-3952-7|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.